NasdaqGS:BRKRLife Sciences
Assessing Bruker (BRKR) Valuation After New Spatial Biology Platforms And Collaboration Updates
Bruker (BRKR) has drawn fresh attention after unveiling its CellScape XR spatial proteomics platform, the PaintScape 3D genome visualization system, and a series of upgrades across its broader multiomics and spatial transcriptomics tools.
See our latest analysis for Bruker.
Despite a busy week of product launches, partnerships, and a fresh dividend declaration, Bruker’s recent share price performance has been weak. The 30 day share price return is 13.83% and the 1 year total shareholder...